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Background
During the development of processes for high produc-
tion CHO fed batch cultures, there is usually insufficient
time for thorough process optimization. Once defined,
these processes often have ranges rather than specific
values for many parameters, resulting in minor varia-
tions in the runs. These small process variations, com-
bined with resultant differences in performance, can be
used to further optimize the process. Over the course of
one year, eleven 20 L fed batch cultures of an antibody
producing CHO-S cell line were generated in the Alle-
gro XRS 20 bioreactor. In addition to normal minor
process variation, small process changes occurred due to
method optimization efforts or culture timing require-
ments. An analysis of the combined historical data was
undertaken to better understand the specific culture
performance drivers, leading to further improvement in
culture outputs, specifically final antibody concentration
and maximum viable cell density (VCD).
Materials and methods
Two different Allegro XRS 20 bioreactors were used for
the 20 L fed batch runs. A monoclonal antibody produ-
cing CHO-S cell line was grown in CD FortiCHO media
fed with EfficientFeed C on five consecutive days and
glucose as needed. In all cases the final expansion was
done in the XRS 20 biocontainer. Table 1 shows a sum-
mary of the process conditions applied throughout the
experimental runs.
Results
An initial evaluation of CHO fed batch cell culture in
the Allegro XRS 20 bioreactor in terms of growth curve
and viability, antibody production, and contaminants
demonstrated excellent reproducibility. This provides an
opportunity to identify relatively small output differ-
ences due to process variation. For the analysis of cell
culture performance drivers, the following input vari-
ables were considered: passage number; initial and final
post expansion seed density; VCD at first feed; agitation;
viability at harvest; and total days in culture - data for
viable cell density over 5 runs is shown in figure 1. In
addition to almost daily sampling for cell count, viabi-
lity, metabolite/nutrient, gases and pH measures, the
final harvest was assayed for mAb, host cell protein
(HCP), and DNA concentrations. These outputs were
used in the analysis as well. The data from these runs
was compiled and analyzed for trends linking the varia-
tions in run parameters with the critical outputs of max-
imum viable cell density and mAb titer.
Conclusions
The Allegro XRS 20 single use bioreactor generated
highly reproducible cell culture performance for this
CHO mAb production process, allowing for a holistic
analysis of relatively small changes in process conditions
and the resultant differences in performance. In three
separate paired runs, the first being identical and the
second two differing by 30 vs. 35 rpm agitation, the par-
allel culture results are extremely similar, highlighting
the overall reproducibility of the system. This bioreactor
reproducibility makes it possible to review historical
data to identify performance drivers that were missed inPall Life Sciences, 20 Walkup Drive, Westborough, MA, 01581, USA
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limited optimization testing done at smaller scale prior
to the 20 L runs. The VCD at the time of the first feed
addition proved very important for overall mAb yield.
Although a relationship was not surprising, the optimal
range was tighter than previously believed. Nutrient feed
timing can be easily modified as there is very good
understanding of the growth curves for this CHO-S cell
line in the Allegro XRS 20 bioreactor. This opportunis-
tic analysis of historical data has some limitations com-
pared to experiments designed specifically to look at
process controls. Despite these limitations the value is
clear, it can provide additional process understanding
without additional experimentation. Thus, this approach
could further understanding of performance drivers for
any production run, and can be expanded to other cell
line / media combinations in any culture system having
sufficient reproducibility to distinguish relatively small
changes in process conditions and the resultant small
but significant differences in performance.
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Table 1. Allegro XRS 20 fed batch process conditions
Cell Line: Industrial suspension CHO producing mAb biosimilar
Seed: 0.3 - 0.5 × 106 viable cells/mL in 5 L CDFortiCHO (Life Technologies)
Expansion: Expand at 2 - 4 viable cells/mL to 14 L
Feeding strategy: CD EfficientFeed C (EFC, Life Technologies), initial feed at 8.0 ± 2.0 M viable cells.mL
Additional bolus feeds every 24 hours for a total of 5 feeds (1.2 L/feed)
Carbon source: Glucose kept above >2 f/L (bolus target >5f/L)
Antifoam C: Added as needed
Aeration rate: 1.0 L/min
DO set point: O2 control at 40%
pH set point: 7.2 ± 0.05
Agitation: 5 L: 25 RPM, 5°X, 5°Y; 14 - 20: 30 or 35 RPM, 15°X, 5°Y
Temperature: 37°C
Figure 1 Viable cell data average of replicate samples (2 or 3).
Agitation at 30 rpm for all runs.
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